DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Recently, Wen-Bin He et al. indicated that XCI pattern of amniocytes can predict the risk of dystrophinopathy in fetal carriers of DMD mutations (He et al., 2019).